ESI BIO’s mission is to be our customer’s trusted partner in translating scientific discoveries to the clinic. We do this by providing breakthrough stem cell technologies as research grade and therapeutic grade products, lighting the path from research to the clinic in order to help our customers with their goal of treating disease. Our product portfolio currently includes pluripotent and progenitor stem cells, hydrogel matrix products, antibodies, small molecules and other reagents for stem cell research.
ESI BIO conducts its operations from multiple locations, including the cities of Alameda and La Jolla, CA, and a location in Singapore. We are a member of the proud family of stem-cell-based subsidiary companies owned by BioTime, Inc., from which we benefit from a deep source of excellent science, intellectual property and stem cell technologies. We emphasize collaboration with our customers as a cornerstone of our strategy and we encourage individuality and autonomy among our staff to nurture creativity.
Company Details
- Address
- 1301 Harbor Bay Parkway, Suite 100, Alameda,ca 94502,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.esibio.com
- Keywords
- PureStem® Progenitor Cells, HyStem® Hydrogels, ESI Human Embryonic Stem Cells, and Small Molecules, Antibodies and Stem Cell Reagents.
- HQ
- Alameda, CA
- Competitors
- IDEO U, Cerus, Daiichi Sankyo US.
Esi Bio - A Division Of Biotime, Inc. Questions
Esi Bio - A Division Of Biotime, Inc.'s website is http://www.esibio.com
Esi Bio - A Division Of Biotime, Inc.'s LinkedIn profile is https://www.linkedin.com/company/esi-bio
Esi Bio - A Division Of Biotime, Inc.'s industry is
Biotechnology Research
Esi Bio - A Division Of Biotime, Inc.'s categories are Biotechnology Research
